TENX CIK: 34956

Tenax Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
5.69
FY22:
3.21
FY23:
11.7
FY24:
96.7
FY25:
104
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.30
FY22:
0.20
FY23:
0.00
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
5.99
FY22:
3.40
FY23:
11.7
FY24:
96.7
FY25:
104

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
1.56
FY22:
1.85
FY23:
3.59
FY24:
4.69
FY25:
7.16
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.18
FY22:
0.06
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.24
FY22:
1.49
FY23:
8.10
FY24:
92.0
FY25:
97.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
5.99
FY22:
3.40
FY23:
11.7
FY24:
96.7
FY25:
104

All amounts in millions USD Data source:SEC EDGAR